Overview
Cyendiv is a 150 mg oral capsule containing Nintedanib, a multi-targeted tyrosine kinase inhibitor. This medication is primarily used to treat idiopathic pulmonary fibrosis (IPF), non-small cell lung cancer (NSCLC), and systemic sclerosis-associated interstitial lung disease (SSc-ILD). It works by targeting and blocking multiple signaling pathways involved in fibrosis, which helps slow disease progression and manage symptoms.





